Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?

U.S. health benefits company Elevance Health, Inc. (ELV) appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average of 15.40X. It also trades at a discount to major health insurance companies like UnitedHealth Group Incorporated (UNH) and Humana Inc. (HUM) , which have forward P/E ratios of 16.46X and 16.86X, respectively. ELV currently holds a Value Score of A.This discounted valuation could reflect market skepticism about ...